How much revenue does Curative Biosciences make?

Curative Biosciences reported $0 in revenue for fiscal year 2017. In Q3 2018 revenue was $0.

What companies are similar to Curative Biosciences?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Sproutly Canada Inc. (SRUTF), Maven Brands Inc. (TRLFF), Rebus Holdings, Inc. (RBSH), Hemagen Diagnostics, Inc. (HMGN).

Curative Biosciences, Inc. (CBDX) Stock

About Curative Biosciences, Inc.

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and...

At a glance

Curative Biosciences reported revenue of $0 for fiscal year 2017, and net income of -$53,195. In Q3 2018 (the quarter ended March 31, 2018) revenue was $0.

Figures from company filings; latest fiscal year ended June 30, 2017.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.